[ad_1]
Source: China Fund News Author: Liddy Time: 2020-12-03
Last night, the British stock market soared due to the approval of the vaccine, and as for US stocks, the S&P 500 Index also reached a new closing high.
Pfizer’s new corona vaccine approved for emergency use in the UK will be available across the country from next week.
According to the US CNN report on December 2 local time, Pfizer and BioNTech announced that they had obtained a temporary authorization for the emergency use of their Covid-19 vaccine in the UK.
The United Kingdom thus became the first country in the world to approve the use of the Pfizer / BioNTech vaccine.
Previously, Pfizer and BioNTech signed a contract with the British government to provide a total of 40 million doses of vaccine to the UK in 2020 and 2021.
British Health Secretary Matt Hancock said the approval of the Pfizer / BioNTech vaccine is great news. He said 50 hospitals are ready to receive the drug and the UK has also set up a large vaccination center.
A spokesman for the Department of Health and Welfare (NHS) said in a statement that the vaccine will be launched across the UK from next week.
The NHS is reported to have decades of experience in providing vaccination on a large scale and will go to great lengths to promote vaccine coverage and provide care and support to all those eligible for vaccination.
The UK’s FTSE 100 index rose more than 1%.
Related vaccine stocks also increased significantly.
Pfizer rose 3.6% and its market value soared by US $ 8 billion (approximately RMB 52.4 billion) overnight. It has increased for four consecutive business days.
Pfizer’s German partner BioNTech was up 6.2%.
Moderna rose more than 600% this year, Merck will collect
Since the beginning of this year, the flagship concept of Moderna vaccine stocks has risen by more than 600%, so some people “can’t sit still.”
On Wednesday, local time, before the US stock market, the pharmaceutical giant Merck announced that it had sold its direct stake in Moderna.
Merck said its direct holding of Moderna shares has made considerable gains, especially in 2020, Moderna’s share price has risen sharply. Merck expects to include the small gains recorded in the fourth quarter as “other business income and expenses.”
Merck is reported to have indirectly retained its investment in Moderna through its hedge fund, and the two companies will continue to cooperate in the development of cancer vaccines.
As early as 2015, Merck began investing in Moderna, and in 2018 invested another $ 125 million in Series H preferred shares with a new price of $ 125 million in Moderna. The two companies have signed licensing and strategic cooperation agreements to cooperate in the development of cancer vaccines.
Moderna fell more than 9% shortly after the market opened, and then the share price rose to 6% and closed 1.41% higher.
Putin ordered: Russia to start mass vaccination next week
According to the World Wide Web, Russian Satellite Network reported yesterday that Russian President Putin has made a request to Deputy Prime Minister Golikova: mass vaccination will begin next week.
According to the report, Putin said that various industries in Russia are ready to vaccinate the new corona vaccine.
Previously, the Russian Ministry of Health registered the world’s first COVID-19 vaccine “Sputnik V” (Sputnik V) on August 11. The vaccine was jointly developed by the Gamallea National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund. Currently, phase III clinical trials have been approved and are taking place in Belarus, the United Arab Emirates, Venezuela, and a number of other countries.
According to the Xinhua News Agency, on December 2, Russia’s Epidemic Prevention Headquarters reported that there were 25,345 new confirmed cases in Russia and a total of 2,347,401 confirmed cases; 589 new deaths, a record for the number of deaths in a single day since the outbreak, with a total of 41,053 deaths.
S&P 500 hits new closing high
Last night, the top three US stock indices fell more than 1% at the open.
In the afternoon, Pelosi and Schumer, the top leaders of the Democratic Party, issued a joint statement in support of the Senate cross-group proposal as the “basis for negotiation.” All three major stock indices rose.
At the close, the Nasdaq index fell 0.05% to 12,349.37 points; the Dow Jones index rose 0.20% to 29,883.79 points.
The S&P 500 Index rose 0.18% and slightly refreshed its closing price to an all-time high of 3.69.01 points;
New Energy Vehicle Shares Recover Overall, Lufax Sinks 10%
Ahead of the US stock market on Wednesday, the ideal auto audience offers November delivery data.
In November, Ideal Auto delivered 4,646 vehicles, a 25.8% increase over the previous month, and achieved a month-over-month increase for 5 consecutive months. As of November 2020, Ideal ONE has delivered a total of 26,498 vehicles.
In addition, Ideal Motors also requested a placement of 47 million ADS shares for a maximum of US $ 36.8, and the number of additional shares to be issued represented 5.6% of the American Depositary Shares issued.
Shortly after opening, the ideal car once fell by more than 11%, but then came back and was up by more than 2%.
Xiaopeng Automobile and Weilai Automobile, which fell sharply on Tuesday, rebounded on Wednesday.
Xiaopeng Motors closed up 7.4% after falling 12%, with a maximum gain of 10% on the day.
Weilai closed up 5.5% after falling 15%, and was once up more than 6% during the session.
However, another star concept in Chinese stocks, Lufax, slumped 10% due to underperformance.
Yesterday, Lufax published its first financial report after listing. The third quarterly report shows that Lufax’s total third-quarter revenue reached 13,076 million yuan (approximately 1,926 million US dollars), an increase of 10.5% over the same period last year; But the net profit was only 2.2 billion yuan, a year-on-year decrease of 36.8%.
Lufax stated that the decrease in net profit for the third quarter was affected by a one-time non-cash expense of 1.3 billion yuan related to the restructuring of round C convertible notes. After excluding the one-time expense, net profit in the third quarter increased slightly by 2%.
The United States diagnoses more than 200,000 cases in a single day
Statistics from Johns Hopkins University in the United States show that as of 4:26 p.m. ET on December 2, the cumulative number of confirmed cases of new coronary pneumonia in the United States exceeded 13.86 million, reaching 13,869,361. The number of deaths from new coronary pneumonia in the United States exceeded 270,000, reaching 272,552. In the past 24 hours, there were 202,891 new confirmed cases and 2,604 new deaths in the United States.
After a week or so, the United States once again confirmed more than 200,000 cases in a single day. According to Bloomberg News, on the 27th local time, the United States reported more than 200,000 new cases of new coronary pneumonia in a single day.
According to Overseas Network, on December 2 local time, Robert Redfield, director of the US Centers for Disease Control and Prevention, issued a warning to the public that, based on the current development of the new epidemic of the crown, the next few months will be very difficult. “In fact, December, January and February will be difficult times. I think these three months will be the most difficult times in the history of American public health, primarily because our health care system will be under significant pressure.” Durfield noted that 90% of hospitals in the United States have been in the red zone with the worst indicators of an epidemic.
